On September 9, NCCAM was pleased to host Patricia Hibberd, M.D., Ph.D., who delivered a lecture at NIH on “Probiotics, the Microbiome, and Host Immune Response: Insights for Novel Therapeutic Approaches.” Dr. Hibberd is professor of pediatrics at Harvard Medical School, and chief of the Division of Global Health at Massachusetts General Hospital for Children, as well as professor of global health at Harvard School of Public Health.
Probiotics are live microorganisms that may have beneficial effects on health and well-being when introduced into the human microbiome. In 2011, Americans spent $28 billion on probiotic foods (particularly yogurt) and supplements, which are widely marketed and readily available. Few of these products have been rigorously studied for their health benefits, however, and science in this area lags far behind the growth in consumer sales and use. To address this evidence gap, NCCAM supports a program of basic, translational, and clinical research on probiotics.
Following the lecture, the NCCAM blog team sat down with Dr. Hibberd for a brief Q and A. Watch it here: